About Perrigo Co. Plc 
Perrigo Co. Plc
Pharmaceuticals & Biotechnology
Perrigo Co. Plc engages in providing over-the-counter (OTC) self-care and wellness solutions. Its solutions enhance individual well-being by enabling consumers to proactively prevent or treat conditions that can be self-managed. The Company operates through three segments: Consumer Self-Care Americas, Consumer Self-Care International and Prescription Pharmaceuticals. The Consumer Self-Care Americas segment comprises the store brand consumer self-care business in the United States (U.S.), Mexico and Canada. The Consumer Self-Care International segment includes the branded consumer self-care business in Europe, along with generic consumer-focused businesses in the United Kingdom (U.K.) and Australia. The Prescription Pharmaceuticals segment commercializes and manufactures generic prescription products in the U.S. and diagnostic products in Israel.
Company Coordinates 
Company Details
The Sharp Building, Hogan Place , DUBLIN None : D02 TY74
Registrar Details
Shareholding Snapshot
Shareholding Compare (%holding) 
Majority shareholders
Domestic Funds
Domestic Funds
Held in 97 Schemes (49.9%)
Foreign Institutions
Held by 153 Foreign Institutions (13.23%)
Strategic Entities with highest holding
Highest Public shareholder
Management
Designation
Mr. Murray Kessler
President, Chief Executive Officer, Director
Mr. Orlando Ashford
Director
Ms. Katherine Doyle
Director
Mr. Bradley Alford
Independent Director
Mr. Rolf Classon
Independent Director
Ms. Adriana Karaboutis
Independent Director
Revenue and Profits:
Net Sales:
1,056 Million
(Quarterly Results - Jun 2025)
Net Profit:
0 Million
Pharmaceuticals & Biotechnology
USD 3,072 Million (Small Cap)
NA (Loss Making)
NA
0.04%
0.72
0.37%
0.69






